Chinese expert consensus on flow cytometric detection of hematological malignant cells in tissue samples.

ABSTRACT: Flow cytometry (FCM), characterized by its simplicity, rapid processing, multiparameter analysis, and high sensitivity, is widely used in the diagnosis, treatment, and prognosis of hematological malignancies. FCM testing of tissue samples not only aids in diagnosing and classifying hematological cancers, but also enables the detection of solid tumors. Its ability to detect numerous marker parameters from small samples is particularly useful when dealing with limited cell quantities, such as in fine-needle biopsy samples. This attribute not only addresses the challenge posed by small sample sizes, but also boosts the sensitivity of tumor cell detection. The significance of FCM in clinical and pathological applications continues to grow. To standardize the use of FCM in detecting hematologic

SUBMITTER: Yang Z 

PROVIDER: S-EPMC11873651 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature